Catalyst Oncology

Cancer and Oncology News

Catalyst Oncology header image 2

Selenium and prostate cancer risk - nutrigenomics unlocks the mystery

June 27th, 2009 · No Comments

Higher selenium levels in the blood may worsen prostate cancer in those men with a certain form of the SOD2 gene, according to a study by researchers at Dana-Farber Cancer Institute the University of California, San Francisco. Conversely, those men with prostate cancer who had a different variant of the SOD2 gene seemed to have

View original here: 
Selenium and prostate cancer risk - nutrigenomics unlocks the mystery

Tags: oncology · oncology center

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.